MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
INMD — InMode Ltd. Ordinary Shares
NasdaqInMode Ltd. Ordinary Shares
$14.09
+0.04(+0.28%)
- O
- 14.06
- H
- 14.15
- L
- 13.99
- V
- 616.31K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About INMD
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
IndustryCommon Stock
SectorNot available
IPO DateAug 8, 2019
Employees660
Stock ExchangeNasdaq
Ticker SymbolINMD
Websitehttps://www.inmodemd.com
Key Financial Statistics
| Market Cap | $810.80M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $12.72 - $16.74 |
| 52-Week Avg Volume | 777.2K |
| VWAP | $14.07 |
| Transactions | 6,456 |
| Total Recorded Bars | 1,798 days |